BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6314211)

  • 1. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
    Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
    Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol and dopaminergic systems.
    Lucchi L; Lupini M; Govoni S; Covelli V; Spano PF; Trabucchi M
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():379-82. PubMed ID: 6685300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related differences in dopamine-stimulated adenylate cyclase sensitivity to "in vivo" chronic ethanol treatment.
    Lucchi L; Govoni S; Trabucchi M
    Alcohol; 1984; 1(4):263-7. PubMed ID: 6100231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
    Fleminger S
    Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol effects on striatal dopamine receptor-coupled adenylate cyclase and on striatal opiate receptors.
    Hoffman PL; Luthin GR; Theodoropoulos D; Cordopatis P; Tabakoff B
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():355-9. PubMed ID: 6314380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic ethanol exposure on adenylate cyclase activities in the rat.
    Rabin RA; Baker RC; Deitrich RA
    Pharmacol Biochem Behav; 1987 Apr; 26(4):693-7. PubMed ID: 3037566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
    Okada F; Horikawa T; Tokumitsu Y; Nomura Y
    Neurochem Int; 1994 Jan; 24(1):23-7. PubMed ID: 8130732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium.
    Mørk A; Geisler A
    Biol Psychiatry; 1989 Jul; 26(3):279-88. PubMed ID: 2568134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
    Andersen PH; Jansen JA
    Eur J Pharmacol; 1990 Jun; 188(6):335-47. PubMed ID: 1973652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G; Norman AB; Hess EJ; Creese I
    J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.